Mercom Capital Group September 9, 2021
Staff

The financial terms of the acquisition were not disclosed

Recuro Health, a digital virtual care platform, acquired MyLifeIQ, an epigenetics and precision medicine platform. The terms of the acquisition were not disclosed.

MyLifeIQ precision medicine platform captures data and delivers the uniqueness of each person, pulling together the variables involved in health, including DNA, wearable data, and lifestyle assessments.

Recently, Recuro Health, announced the acquisition of SupDoc, an AI-enabled virtual health solution for care delivery. The financial terms of the acquisition were not disclosed.

Recuro offers a cloud-based virtual care platform with a curated suite of digital solutions – from primary care and behavioral health to at-home testing and genetic screening. According to the company, these digital solutions allow patients to engage with physicians,...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Digital Health, Health IT, Mergers & Acquisitions / JV, Pharma / Biotech, Precision Medicine, Technology, Telehealth, Trends
AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights
Physician viewpoint: Precision medicine is a 'great deal,' regardless of cost
Why precision medicine will buck typical consolidation trends